Literature DB >> 1646116

Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses.

A B Sabin.   

Abstract

Poliomyelitis caused by polioviruses has already been eradicated from industrialized countries of North America, Europe, Asia and Oceania, but the procedures by which this eradication was achieved are not adequate for the poor tropical and subtropical countries. The major challenge now is first to eliminate it rapidly from Asia and Africa where an estimated 250,000 cases and 25,000 deaths currently occur annually. The great progress toward eradication of "wild" polioviruses from poor tropical and subtropical countries in Latin America was achieved not by the procedures still recommended by the WHO Expanded Program on Immunization (EPI) but by the independently organized annual, national days of antipolio vaccination - all based on the use of large armies of well-trained non-professional, community volunteers - first used in Cuba (1962), Brazil (1980), Nicaragua (1981), Dominican Republic (1983), Paraguay (1985), and Mexico (1986). This novel approach, described in some detail in this communication, is recommended for the rapid elimination of wild polioviruses from Asia and Africa, and for ultimate global eradication with the help of a special cadre within the EPI of WHO. The extensive use by the Pan American Health Organization (PAHO) of highly sophisticated regional virus laboratories has led to the recognition that, in areas from which poliomyelitis caused by polioviruses has been largely eliminated, there are thousands of cases of acute flaccid paralysis, previously clinically diagnosed as "probable poliomyelitis", that have no viral etiology, a phenomenon previously reported by Dr. Manuel Ramos Alvarez in Mexico City in 1967.

Entities:  

Keywords:  Communicable Disease Control; Delivery Of Health Care; Developing Countries; Diseases; Health; Health Services; Immunization; International Agencies; Organizations; Primary Health Care; Un; Vaccination; Vaccines; Viral Diseases--prevention and control; Who

Mesh:

Substances:

Year:  1991        PMID: 1646116     DOI: 10.1007/bf00237353

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  44 in total

1.  Two voluntary mass immunization programs using Sabin oral vaccine.

Authors:  R B JOHNS; S FARNSWORTH; H THOMPSON; F BRADY
Journal:  JAMA       Date:  1963-01-19       Impact factor: 56.272

2.  Poliomyelitis incidence in the Soviet Union in 1960.

Authors:  A B SABIN
Journal:  JAMA       Date:  1961-04-22       Impact factor: 56.272

3.  Present position of immunization against poliomyelitis with live virus vaccines.

Authors:  A B SABIN
Journal:  Br Med J       Date:  1959-03-14

4.  International Task Force for Disease Eradication.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1990-04-06       Impact factor: 17.586

5.  Oral poliovirus vaccine. Recent results and recommendations for optimum use.

Authors:  A B SABIN
Journal:  R Soc Health J       Date:  1962 Mar-Apr

6.  Neurovirulence in cynomolgus monkeys of enterovirus 71 isolated from a patient with hand, foot and mouth disease.

Authors:  I Hashimoto; A Hagiwara; H Kodama
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

7.  Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world.

Authors:  A B Sabin
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

8.  Measles, killer of millions in developing countries: strategy for rapid elimination and continuing control.

Authors:  A B Sabin
Journal:  Eur J Epidemiol       Date:  1991-01       Impact factor: 8.082

9.  Evolution of the poliomyelitis vaccination program in Costa Rica.

Authors:  E M León de Coto
Journal:  Rev Infect Dis       Date:  1984 May-Jun

10.  Strategies for elimination of poliomyelitis in different parts of the world with use of oral poliovirus vaccine.

Authors:  A B Sabin
Journal:  Rev Infect Dis       Date:  1984 May-Jun
View more
  4 in total

Review 1.  Patterns of polyomavirus SV40 infections and associated cancers in humans: a model.

Authors:  Janet S Butel
Journal:  Curr Opin Virol       Date:  2012-07-06       Impact factor: 7.090

2.  SV40 seroprevalence in two Latin American countries involved in field trials of candidate oral poliovaccines.

Authors:  Connie Wong; Shaojie Zhang; Ervin Adam; Lawrence Paszat; Janet S Butel
Journal:  J Infect       Date:  2019-04-06       Impact factor: 6.072

3.  The impact of the economic crisis and the US embargo on health in Cuba.

Authors:  R Garfield; S Santana
Journal:  Am J Public Health       Date:  1997-01       Impact factor: 9.308

Review 4.  Future of polio vaccines.

Authors:  Ellie Ehrenfeld; John Modlin; Konstantin Chumakov
Journal:  Expert Rev Vaccines       Date:  2009-07       Impact factor: 5.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.